
Novavax will inject 131 volunteers in the first phase of the trial testing the safety of the vaccine and looking for signs of its effectiveness, the company's research chief Dr. Gregory Glenn said.
from International-News-Economic Times https://ift.tt/2TUjI3d
via
IFTTT
0 comments:
Post a Comment